Blood Thinner Costs: How Seniors Can Afford Eliquis and Xarelto
Eliquis (apixaban) and Xarelto (rivaroxaban) are among the most commonly prescribed blood thinners for seniors managing conditions like atrial fibrillation, deep vein thrombosis, or stroke prevention. They're also among the most expensive brand-name drugs on the market. If you're on a fixed income and staring down a monthly prescription bill that rivals a car payment, you're not alone — and there are legitimate ways to reduce what you pay. Here's what you need to know about how pricing works and where the real savings opportunities are.
Why These Drugs Cost So Much to Begin With
Both Eliquis and Xarelto belong to a class called direct oral anticoagulants (DOACs). They replaced older blood thinners like warfarin for many patients because they require less monitoring and have more predictable dosing. That clinical convenience comes with a price: neither has a widely available generic equivalent in the U.S. at the scale that would dramatically lower costs. Eliquis in particular has faced delays in generic competition due to patent litigation, though that landscape is gradually shifting.
Without insurance or assistance programs, the list price for a monthly supply of either drug can run into hundreds of dollars. What any individual actually pays, however, depends heavily on their specific coverage situation.
How Medicare Affects What You Pay 💊
Most seniors rely on Medicare Part D (prescription drug coverage) for drugs like Eliquis and Xarelto. Here's how the cost layers work:
- Formulary placement matters. Each Part D plan assigns drugs to tiers. Higher tiers generally mean higher cost-sharing. Both Eliquis and Xarelto are brand-name drugs and typically land on higher tiers, though placement varies by plan.
- The coverage gap ("donut hole") has changed significantly in recent years, and further changes under the Inflation Reduction Act continue to reshape out-of-pocket limits for Medicare beneficiaries. The specifics depend on the plan year and the plan itself.
- Catastrophic coverage kicks in after you've spent a certain amount out of pocket in a plan year, reducing your costs significantly — but getting there can still be painful.
- Plan selection makes a real difference. Two Medicare Part D plans in the same zip code can have dramatically different cost-sharing structures for the exact same drug. Using Medicare's Plan Finder tool during open enrollment each year is one of the most practical things a beneficiary can do.
The Medicare Extra Help Program
Extra Help (also called the Low Income Subsidy, or LIS) is a federal program that reduces Part D premiums, deductibles, and copays for seniors who qualify based on income and resources. For people who are eligible, it can substantially reduce what they pay for expensive brand-name drugs like these.
Eligibility is based on income and assets relative to federal poverty guidelines. Some people are automatically enrolled; others need to apply through the Social Security Administration. It's consistently underutilized — meaning many eligible seniors aren't receiving it simply because they haven't applied.
Manufacturer Assistance Programs
Both Bristol-Myers Squibb/Pfizer (makers of Eliquis) and Janssen (maker of Xarelto) offer patient assistance programs for people who qualify. These are typically aimed at patients who:
- Are uninsured or underinsured
- Do not qualify for or are not enrolled in Medicare
The rules matter here: manufacturer copay cards and assistance programs generally cannot be used with Medicare due to federal anti-kickback rules. Seniors on Medicare Part D typically cannot use these cards at the pharmacy, even if they find them online. This is a common source of confusion.
For Medicare patients, the more relevant pathways tend to be:
- Extra Help / LIS (as described above)
- State Pharmaceutical Assistance Programs (SPAPs), which vary by state and can wrap around Medicare coverage
- Nonprofit patient assistance organizations, such as the Patient Advocate Foundation or NeedyMeds, which help navigate options
Generic Availability: A Changing Picture
The generic landscape for both drugs is evolving. Generic versions of apixaban (Eliquis) have begun entering the market following patent disputes, though availability, pricing, and insurance coverage vary significantly depending on timing, location, and plan. Generic rivaroxaban (Xarelto) has also seen some movement.
Whether a generic is available, covered by your specific plan, and priced lower than the brand in your situation are all questions that require checking current formularies. A pharmacist can be a valuable resource here — they can tell you whether a generic is currently dispensable and what your plan covers.
Comparing Your Options: A Quick Reference
| Pathway | Who It Typically Helps | Key Consideration |
|---|---|---|
| Medicare Part D plan selection | Most seniors on Medicare | Plans vary widely — annual review is essential |
| Medicare Extra Help / LIS | Lower-income Medicare beneficiaries | Must apply; many eligible people don't |
| State Pharmaceutical Assistance Programs (SPAPs) | Varies by state | Check your state's program directly |
| Generic substitution | Patients whose plan covers generics | Availability and coverage are still inconsistent |
| Manufacturer patient assistance | Uninsured / underinsured (not Medicare) | Generally not usable with Medicare Part D |
| Nonprofit assistance organizations | Patients navigating complex situations | Can help identify options you may have missed |
What Actually Determines Your Out-of-Pocket Cost 🔍
No two seniors end up paying the same amount for these drugs, because the final cost is shaped by multiple intersecting factors:
- Which Part D plan you're enrolled in and how it tiers your specific drug
- Whether you qualify for Extra Help and at what level
- Which phase of the Part D benefit you're currently in (deductible, initial coverage, catastrophic)
- Whether a generic is available and covered under your plan
- Your state of residence and whether state assistance programs apply
- Your prescribing doctor's flexibility — in some cases, a therapeutic alternative within the same drug class may be covered differently, though any changes require your physician's involvement
Practical Steps Worth Taking
If you're currently struggling with the cost of Eliquis or Xarelto, a few conversations are worth having:
- Talk to your pharmacist. They often know about generic availability, plan-specific pricing, and assistance resources before patients do.
- Contact your State Health Insurance Assistance Program (SHIP). SHIP counselors provide free, unbiased help navigating Medicare coverage options — including Part D plan comparisons and Extra Help applications.
- Ask your prescriber. They may be aware of clinical alternatives, samples, or prior authorization pathways that affect cost. Never stop or adjust a blood thinner without medical guidance — these are high-stakes medications.
- Review your Part D plan every open enrollment period. Drug formularies change annually. A plan that covered your medication affordably last year may not be the best option this year.
The cost landscape for these drugs is genuinely complex, and what works for one person may not work for another. But the resources above are real, and for many seniors, the gap between what they're currently paying and what they could be paying is significant — it just takes knowing where to look.
